Ex vivo organ support system

A system for supporting and monitoring bioengineered organs addresses the organ shortage and rejection issues by actively managing conditions to ensure compatibility and functionality, enhancing the effectiveness of bioengineered organs and tissues.

JP2024540890APending Publication Date: 2024-11-06MIROMATRIX MEDICAL INC
View PDF 3 Cites 0 Cited by

Patent Information

Application Number
JP2024523150
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2021-10-18
Filing Date
2022-10-18
Publication Date
2024-11-06

AI Technical Summary

Technical Problem

The shortage of organs for transplantation and the challenge of organ rejection in transplants necessitate the development of bioengineered organs (BEOs) and advanced bioengineered tissues (ATs) to reduce rejection and shorten waiting times, while ensuring compatibility and functionality.

Method used

A system for supporting and monitoring bioengineered organs and tissues, including an enclosure, blood circuit, pumps, gas transfer, and a controller, which actively monitors and adjusts conditions to ensure compatibility and functionality before and during implantation.

Benefits of technology

The system reduces labor requirements and enhances the compatibility and functionality of bioengineered organs by automatically monitoring and adjusting conditions, ensuring optimal health status and reducing the risk of rejection.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2024540890000001_ABST
    Figure 2024540890000001_ABST
Patent Text Reader

Abstract

The system (200) for supporting a patient organ may include a primary circuit (212b), a secondary circuit (212a), and a controller (214). The primary circuit may include an inlet configured to connect to a patient (54), an outlet configured to connect to the patient, and a primary pump (206a). The secondary circuit may be connected to the primary blood circuit and may include an enclosure (202) configured to support the organ (50) therein in the blood flow, a secondary pump, a gas transfer unit (208), and a secondary sensor (238a). The controller may be configured to activate the gas transfer unit based on the secondary sensor signal. The organ may be a bioengineered organ. In one embodiment, the organ is a liver, serving to perform liver functions in place of or in support of the patient's liver. TIFF2024540890000002.tif102147
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] Claiming priority This patent application claims the benefit of priority under 35 USC Section 119(e) to U.S. patent application Ser. No. 63 / 257,004, entitled "EXTRACORPOREAL ORGAN SUPPORT SYSTEM," filed on October 18, 2021, to Aleksandr Katane; which is incorporated herein by reference in its entirety. [Background technology]

[0002] background Organ transplants are common throughout the United States and around the world. Organs such as the liver, kidney, pancreas, lungs, and heart are commonly transplanted to prolong the life of the recipient. However, there is often a shortage of organs, creating a demand and waiting list for organs. One solution to this shortage is the use of bioengineered organs and replacement tissues; in this case, the organ can be stripped of its cells and the recipient's cells can be perfused into the bioengineered organ to help prevent rejection. Summary of the Invention

[0003] [Brief description of the drawings]

[0004] In the accompanying drawings, which are not necessarily to scale, like numbers may describe like components in different drawings. Like numbers with different subscripts may represent different instances of the like components. The drawings generally illustrate, by way of example, but not by way of limitation, various aspects discussed in the present document.

[0005] [Figure 1] 1 illustrates an overview of devices and systems involved in the various stages of bioengineered organ transplantation. [Diagram 2] 1 illustrates a schematic of a system for growth and support of bioengineered organs. [Diagram 3] 1 illustrates a schematic of a system for growth and support of bioengineered organs. [Figure 4] 1 illustrates a schematic of how to operate a system for the growth and support of bioengineered organs. [Diagram 5] FIG. 1 illustrates an architecture block diagram for an exemplary computing system that may be used. [Figure 6] 1 illustrates a schematic of a system for growth and support of bioengineered organs. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0006] Detailed Description Bioengineered organs (BEOs) and bioengineered tissues (ATs) may help reduce rejection and shorten organ wait times. BEOs may also help shorten wait times by utilizing organs from different species. In some embodiments, the BEO or AT may be connected to the patient extracorporeally to test the AT or BEO prior to implantation or to provide additional functional support to a patient who may be experiencing organ failure or reduced organ function. In such embodiments, the organ may be connected to the patient using a support system to monitor the condition of the patient and the AT or BEO.

[0007] For example, the system may actively monitor the functionality of the stored AT or BEO while the AT or BEO is connected to the patient to ensure it meets specifications prior to implantation while also optionally helping to improve the patient's health prior to implantation. The system may also monitor the health of the AT or BEO, as well as the health of the patient and the patient's organs while the AT or BEO is connected to the patient to help ensure organ compatibility. These functions may also be performed automatically by the system. By automatically adjusting the operation of the system or by automatically monitoring the health of the patient or organs, the system may help reduce the labor requirements necessary to support a patient using a BEO or AT.

[0008] The above description is intended to provide an overview of the contents of this patent application, and is not intended to provide an exclusive or exhaustive description of the present invention. The following description is included to provide further information about this patent application.

[0009] FIG. 1 illustrates an overview of devices and systems involved in the stages of implantation of a BEO in accordance with at least one embodiment of the present disclosure.

[0010] Exemplary procedure 100 illustrates various stages that may be included in a transplantation procedure. In stage 102, an organ is received from a human or other species donor, such as a pig, sheep, or cow. The organ is decellularized under carefully controlled conditions in a laboratory to remove all (or substantially all) cellular material from the organ. Following decellularization, the organ is recellularized in stage 104, whereby cells from the donor (or other source) are added to the organ; and the organ may be functionally tested or otherwise prepared for implantation. Once the BEO is determined to be ready for transplantation, the BEO may be prepared for transport in stage 106. In stage 108, the BEO or AT may be connected to the patient to provide patient support, test organ compatibility, etc. The BEO may then be implanted in the recipient body in a transplant operation in stage 110. Further details of some of these stages are described in more detail below with respect to Figures 2-6.

[0011] 2 illustrates a schematic diagram of a system 200 for supporting and maintaining a patient using a bioengineered organ (BEO). The system 200 may include an enclosure 202, a blood circuit 204, a pump 206 (including pump 206a, pump 206b, and pump 206c), a gas transfer system 208, and a heating / cooling system 210. The circuit 204 may include a secondary circuit 212a, a primary circuit 212b, and a bypass 212c. The system 200 may also include a controller 214 and an infusion system 216. Also shown in FIG. 2 is an organ 50, which may be, for example, a liver, blood 52, which may be a fluid, and a patient 54.

[0012] The enclosure 202 may be an enclosure configured to support the organ 50 therein in a flow of blood or medium. The enclosure 202 may include a blood inlet 202a and a blood outlet 202b for receiving blood flow through the enclosure and through the organ 50. The enclosure 202 may be a rigid or semi-rigid container, enclosure, or housing made of a material such as one or more of metal, plastic, foam, elastomer, ceramic, composite, or combinations thereof, such as polycarbonate. The enclosure 202 may be transparent or translucent to provide visibility of the organ 50 therein for an operator or technician. Optionally, the enclosure 202 may be configured to limit exposure of the organ 50 to light. The enclosure 202 may include one or more latches, fasteners, or the like to resealably close the lid. In some embodiments, the enclosure 202 may include one or more hinges. The enclosure 202 may include one or more layers of insulation to help thermally isolate the contents of the enclosure 202 from ambient conditions. The enclosure 202 may include a seal between a lid of the enclosure 202 and the container.

[0013] The enclosure 202 may be configured to receive and support a bioengineered organ therein in a blood flow and / or in a fluid bath. That is, the enclosure 202 may be shaped to support an organ therein. In some embodiments, the enclosure 202 may be organ-specific (e.g., kidney-specific), such that the enclosure 202 is shaped to support a kidney (or other organ in other embodiments). In some embodiments, the organ-specific enclosure 202 may be removable and replaceable as needed for transporting the organ. The blood inlet 202a and blood outlet 202b may include a sterile-quick connect for isolating the enclosure 202 from the blood circuit 204.

[0014] The system 200 may also include a weight sensor 213 connected to the enclosure 202. The weight sensor 213 may be in communication with a controller 214, such as to transmit a weight signal thereto. The controller 214 may determine a weight or volume of the fluid in the enclosure 202 and, optionally, control various components of the system, such as the pump 206, based on that weight or volume.

[0015] The secondary circuit 212a of the blood circuit 204 may be connected to the blood inlet 202a and the blood outlet 202b and may be configured to route blood through the system 200 and its components. A bypass 212c may connect the secondary circuit 212a to the primary circuit 212b, such as to allow the flow rates through the secondary circuit 212a and the primary circuit 212b to vary or differ.

[0016] The circuit 204 may be made of one or more types of tubing, including rigid, semi-rigid, and flexible tubing on a variety of materials (e.g., copper, steel, aluminum, plastic, or silicone). Optionally, the tubing of the circuit 204 may be low-shed or pharmacy grade tubing. Additionally, the blood circuit 204 may be configured to have relatively few restriction points throughout the blood circuit 204 to help reduce pressure drop through the blood circuit 204, which may help increase accuracy between the pressure measured outside the organ 50 and at the pressure sensor and the pressure at or within the organ 50.

[0017] The tubing of the secondary circuit 212a or circuit 204 may optionally connect directly to the perfusion vessels of the organ 50, which may allow for an independent vascular interface. Although blood is generally discussed with respect to FIG. 2, the blood circuit may be configured to handle one or more other fluids, such as media or perfusate. In some embodiments, the patient's blood may be used in the circuit 204.

[0018] Pumps 206a, 206b, and 206c may each be connected to circuit 204 and configured to circulate blood through blood circuit 204. Pump 206 may be a positive displacement pump, a centrifugal pump, or an axial pump. Pump 206 may be a low shear pump to help limit fluid damage, and may optionally be reversible. In some embodiments, pump 206 may be a continuous type pump or a peristaltic type pump (with or without damping).

[0019] Pump 206a may be connected to primary circuit 212b, such as downstream of enclosure 202 and upstream of patient 54. Pump 206b may be connected to primary circuit 212b downstream of patient 54. Pump 206c may be connected to bypass 212c. In other embodiments, pumps 206a-206c may be connected to other portions of blood circuit 204. Optionally, the system may include more or fewer pumps.

[0020] The gas transfer unit 208 may be connected to the secondary circuit 212a of the blood circuit 204 and may be configured to transfer gases, such as oxygen, nitrogen, argon, and carbon dioxide (CO2), to and from the blood. The gas transfer unit 208 may be either an active or passive gas transfer unit configured to maintain a desired concentration range, for example, of oxygen and CO2, in the blood. In some embodiments, the gas transfer unit 208 may manage other gases that contribute to organ support. The gas transfer unit 208 may be located upstream of the enclosure 202, such as to exchange gases with the blood before it enters the organ 50. The gas transfer unit 208 may optionally include a heat exchanger configured to exchange heat between the blood of the blood circuit 204 and the heating and cooling system 210, such as to maintain the temperature of the blood before it enters the organ 50. Optionally, a separate heat exchanger may be used in the system 200. Optionally, the gas transfer unit 208 may be an oxygenator.

[0021] The warming / cooling system 210 may be connected to the blood circuit 204 for heat exchange with the blood such that the blood is delivered to the enclosure 202 within a target temperature range. The warming / cooling system 210 may be connected to the gas transfer unit 208, such as to allow a heat exchanger of the gas transfer unit 208 to exchange heat with the blood in the blood circuit 204, such as secondary circuit 212a. For example, a supply line 218 and a return line 220 may connect the warming / cooling system 210 to the gas transfer unit 208, such as to a heat exchanger of the gas transfer unit 208.

[0022] The warming / cooling system 210 may be a warming system in some embodiments and may be a cooling system in some embodiments. In some embodiments, the system 210 may include separate warming and cooling systems. For example, the system 210 may include a resistive heater, a fan, and a heat exchanger. In other embodiments, the system 210 may be a refrigerant heat pump, including, for example, a compressor, a condenser, an evaporator, one or more expansion valves, and a reversing valve. In some embodiments, the system 210 may be a thermoelectric warming and cooling device (Peltier device). In some embodiments, the system may include a refrigeration and cooling system and a resistive electric warming device. In any of these examples, the system 210 may include a heat exchanger configured to indirectly exchange heat with the blood. Optionally, the system 210 may include an emergency cooling system. Optionally, the gas transfer unit 208 may include or be connected to one or more gas tanks 222. Gas tank 222 may be configured to deliver one or more of carbon dioxide, dioxygen, nitrogen, or argon to gas transfer unit 208. Gas tank 222 may be connected to gas transfer unit 208 by filter 225.

[0023] System 200 may optionally include or be connected to a power supply that may be configured to power pump 206, heating / cooling system 210, gas transfer unit 208, various sensors of system 200, a controller, user interface 254, and / or other components of system 200. Optionally, the power supply may be an uninterruptible power supply to help provide constant operation of system 200 even during loss of input power.

[0024] The controller 214 may be a programmable controller, such as a single-board or multi-board computer, a direct digital controller (DDC), or a programmable logic controller (PLC). In other embodiments, the controller 214 may be any computing device, such as a handheld computer, e.g., a smartphone, tablet, laptop, desktop computer, or any other computing device that includes a processor, memory, and communication capabilities. The controller 214 may be configured to control the operation of the system 200 generally, such as by controlling the operation of the pump 206, the gas transfer unit 208, the heating / cooling system 210, the power source, any sensors (such as those described below), or the infusion system 216. Various examples of how the controller 214 may control one or more components of the system 200 to support or grow the organ 50 are described below with reference to FIG. 3.

[0025] The secondary circuit 212a may optionally include an inlet control valve 224a and an outlet control valve 224b. The inlet control valve 224a and the outlet control valve 224b may each be a modulating or isolation valve in communication with a controller and may be actuated by the controller, such as to isolate the enclosure 202 and the organ 50, such as to remove the enclosure 202 and the organ 50 from the system 200. Optionally, the inlet control valve 224a and the outlet control valve 224b may be in communication with the controller 214, and the controller 214 may actuate the inlet control valve 224a or the outlet control valve 224b to regulate flow through the enclosure 202 and the organ 50. The primary circuit 212b and the bypass 212c may also include one or more control valves.

[0026] The infusion system 216 may include a housing 226, a heating / cooling system 228, pumps 230a-c, and tanks 232a-c. The infusion system 216 may be configured to infuse one or more nutrients or fluids into a blood circuit 204, such as the secondary circuit 212a. The outputs of each pump 230 may be connected or manifolded together and connected to the blood circuit 204, such as upstream of the blood inlet 202a. Optionally, the infusion system 216 may connect to the blood circuit 204 at another location. Optionally, each pump 230 may include a check valve therein or associated therewith. Optionally, the pumps may include inherent check valve capabilities such that they cannot pump beyond each other when manifolded or connected together.

[0027] The enclosure 226 may include one or more walls and insulation, such as to provide a temperature controlled environment within the enclosure 226. The enclosure 226 may be made of materials such as one or more of metal, plastic, foam, elastomer, ceramic, composite, or combinations thereof. The enclosure 226 may be transparent or translucent (or may include transparent or translucent portions, such as windows) to provide visibility of the pump 230 and the tank 232. Optionally, the enclosure 226 may be configured to limit exposure of the tank 232 to light. The enclosure 226 may include one or more latches, fasteners, or the like, to resealably close the door or lid. In some embodiments, the enclosure 226 may include one or more hinges to connect the door. The enclosure 226 may include a seal between the door of the enclosure 226 and the container.

[0028] The pumps 230 may each be configured to pump fluid therethrough and to eject fluid into the blood circuit 204. Each of the pumps 230 may be any of the pump types described above with respect to the pump 206. The reservoirs 232 may each be a storage container made of one or more of metal, plastic, foam, elastomer, ceramic, composite, combinations thereof, and the like. The reservoirs 232 may each be configured to store fluid to be infused into the blood circuit 204 as needed or as determined by an operator of the controller 214. Although three reservoirs and pumps are shown in the figure, the infusion system 216 may include one, two, four, five, six, seven, eight, nine, ten, etc. reservoirs or pumps.

[0029] Tank 232 may contain cell culture medium, cells, glutamine, glucose, buffers, sodium chloride, essential amino acids, non-essential amino acids, drugs, ammonia (ammonium chloride), HEPES (C8H 18The pump 230 may be configured to store, and delivered to pump, one or more of N2O4S), sodium bicarbonate, insulin, epinephrine, albumin, linoleic acid, dexamethasone, or glucagon. Medications include (R)-warfarin, (S)-mephenytoin, acetaminophen, aprepitant, azoles, benzodiazepines, beta, caffeine, calcium, carbamazepine, celecoxib, clarithromycin, codeine, cyclosporine, delavirdine, dextromethorphan, diazepam, diclofenac, enalapril, erythromycin, estradiol, estrogen, fentanyl, finasteride, flecainide, fluoxetine, glipizide, glyburide, haloperidol, indinavir, indomethacin, lidocaine, lopinavir, loratidine, methamide, methacrylate crosspolymer ... The active ingredient may be one or more of: tadone, mexiletine, morphine, nelfinavir, nifedipine, olanzapine, omeprazole, opioids, pentamidine, phenothiazines, phenytoin, piroxicam, prednisone, progesterone, propranolol, quinidine, risperidone, ritonavir, selective serotonin reuptake inhibitors, saquinavir, sildenafil, sirolimus, statins, tacrine, tacrolimus, tamoxifen, testosterone, theophylline, tramadol, trazodone, tricyclic, valproate, venlafaxine, verapamil, or voriconazole.

[0030] The infusion system 216 may be controlled, such as by the controller 214, to infuse one or more fluids into the blood circuit 204, such as to treat, grow, or support the organ 50 within the enclosure 202. Further details of the operation of the system 200 and the infusion system 216 are described below with respect to FIG.

[0031] The secondary circuit 212a may optionally include an air bubble sensor 234 connected to the secondary circuit 212a and downstream of the bypass 212c and therefore downstream of all pumps 206, which allows for the detection of air bubbles upstream of the organ 50. The air bubble sensor 234 may be in communication with the controller 214. An air bubble trap 236 may be located in the secondary circuit 212a, such as downstream of the secondary circuit 212a and downstream of the bypass 212c, and therefore downstream of all pumps 206, which allows for the collection of air bubbles created by agitation during pumping upstream of the organ 50.

[0032] The secondary circuit 212a may optionally include inlet sensors 238a, which may optionally include one or more of a pressure sensor, a temperature sensor, a flow meter, a glucose sensor, a lactate sensor, an O2 sensor, a CO2 sensor, a pH sensor, or other sensors. Each sensor may be connected to the secondary circuit 212a upstream of the enclosure 202 (and may optionally be within the enclosure 202). Similarly, outlet sensors 238b may optionally include one or more of a pressure sensor, a temperature sensor, a flow meter, a glucose sensor, a lactate sensor, an O2 sensor, a CO2 sensor, an organ health sensor, or other sensors. Each sensor may be connected to the secondary circuit 212a downstream of the enclosure 202 (and may optionally be within the enclosure 202). Although the sensors are shown in FIG. 2 as having specific locations, in other embodiments the sensors may be positioned in various locations.

[0033] For example, a temperature sensor may be located upstream of the enclosure 202 or downstream of the enclosure 202. The inlet temperature sensor may be configured to generate an inlet temperature signal based on the inlet temperature of blood entering the enclosure 202. The outlet temperature sensor may be configured to generate an outlet temperature signal based on the outlet temperature of blood leaving the enclosure 202. The temperature sensor is any type of fluid temperature sensor, such as a thermistor, thermocouple, or resistance temperature detector, either in a thermowell connected to the pipes of the circuit 204 or in direct contact with the process fluid. The inlet sensor group 238a or the outlet sensor group 238b may include other sensor options, some examples of which are described below.

[0034] In another embodiment, an inlet glucose sensor may be connected to the secondary circuit 212a, such as upstream of the enclosure 202. Similarly, an outlet glucose sensor may be connected to the secondary circuit 212a, such as downstream of the enclosure 202. The glucose sensor may be configured to generate a glucose sensor signal based on the glucose level of the blood. Similarly, an organ health sensor may be connected to the secondary circuit 212a, such as upstream or downstream of the enclosure 202. The organ health sensor may be configured to generate an organ health sensor signal based on a metabolite level of the blood in the circuit 204. An inlet CO2 sensor may be connected to the secondary circuit 212a upstream of the enclosure 202. An outlet CO2 sensor may be connected to the secondary circuit 212a downstream of the enclosure 202. Each of the inlet CO2 sensor and the outlet CO2 sensor may be a carbon dioxide sensor configured to generate a carbon dioxide signal based on the respective CO2 level of the blood. An inlet O2 sensor may be connected to the secondary circuit 212a upstream of the enclosure 202. An outlet O2 sensor may be connected to the secondary circuit 212a downstream of the enclosure 202. Each of the inlet O2 sensor and the O2 sensor may be an oxygen sensor configured to generate an oxygen signal based on a respective O2 level of the blood. An inlet pressure sensor may be connected to the secondary circuit 212a upstream of the enclosure 202 and configured to generate an inlet pressure signal based on the pressure of the blood getting into the enclosure 202. An outlet pressure sensor may be connected to the secondary circuit 212a upstream of the enclosure 202 and configured to generate an inlet pressure signal based on the pressure of the blood getting into the enclosure 202. Any or all of the sensor signals may be transmitted to the controller 214.

[0035] Sampling port 240a may be connected to secondary circuit 212a (e.g., upstream of pump 206a) and may be configured to receive a syringe to draw a sample of blood without compromising the sterility of the blood in secondary circuit 212a. Sampling port 240b may be connected to secondary circuit 212a (e.g., downstream of pump 206a) and may be configured to receive a syringe to draw a sample of blood without compromising the sterility of the blood in secondary circuit 212a. And blood circuit 204 may include one or more administration ports; the administration ports may be configured to receive nutritional supplements for delivery to the blood and ultimately to the organs without compromising the sterility of the blood in circuit 204.

[0036] The primary circuit 212b may optionally include an air bubble sensor 242 connected to the primary circuit 212b downstream of the bypass 212c, and thus downstream of the pump 206a and upstream of the patient 54, which allows for air bubbles to be detected upstream of the patient 54. The air bubble sensor 234 may be in communication with the controller 214. An air bubble trap 244 may be located in the primary circuit 212b downstream of the secondary circuit 212a and downstream of the bypass 212c, and thus downstream of the pump 206a, etc., which allows for collecting or trapping air bubbles created by agitation during pumping upstream of the patient 54.

[0037] The primary circuit 212b may also include a secondary inlet sensor group 246a, which may include one or more of a pressure sensor, a temperature sensor, a flow meter, a glucose sensor, a lactate sensor, an O2 sensor, a CO2 sensor, a pH sensor, or other sensors. Each sensor may be connected to the primary circuit 212b upstream of the patient 54. Similarly, the primary circuit 212b may include a secondary outlet sensor group 246b, which may optionally include one or more of a pressure sensor, a temperature sensor, a pH sensor, a flow meter, a glucose sensor, an O2 sensor, a CO2 sensor, an organ health sensor, or other sensors. Each sensor may be connected to the primary circuit 212b downstream of the patient 54. Although the sensors are shown in FIG. 2 as having specific locations, in other embodiments the sensors may be positioned in various locations.

[0038] The primary circuit 212b may also include a sample port 248a, which may be connected to the primary circuit 212b (e.g., upstream of the patient 54) and may be configured to receive a syringe to draw a sample of blood without compromising the sterility of the blood in the primary circuit 212b. A sampling port 248b may be connected to the primary circuit 212b (e.g., downstream of the patient 54) and may be configured to receive a syringe to draw a sample of blood without compromising the sterility of the blood in the primary circuit 212b. And the primary circuit 212b may also include an administration port 250, which may be configured to receive a nutritional supplement for delivery to the blood and ultimately to the patient 54 and organs 50 without compromising the sterility of the blood in the circuit 204.

[0039] The primary circuit 212b may also include an air bubble sensor 252 that may be located upstream of the patient 54 and in communication with the controller 214. The controller 214 may be configured to shut down the system 200 if the air bubble sensor 252 detects an air bubble to help protect the health and safety of the patient 54.

[0040] 3 illustrates a schematic diagram of a system 200 for supporting a patient 54 using a bioengineered organ. The system 200 may be the same as or similar to the system 200 described above with respect to FIG. 2; FIG. 3 illustrates how the various components may be connected to a controller 214.

[0041] The pump 206, gas transfer unit 208, cooling system 210, primary sensors 246, secondary sensors 238, injection system 216, and control valve 224 may be connected to the controller. The cooling system 228 and pump 230 may be connected directly to the controller 214 or may be connected to the controller 214 through the controller of the injection system 216 or other devices.

[0042] The user interface 254 may be any display and / or input device. For example, the user interface 254 may be a touch screen display, a computer, a tablet, a phone, or the like. In another embodiment, the user interface 254 may provide lights, buttons, and / or switches. The user interface 254 may be in communication with the controller 214 and may be configured to operate the controller 214 and devices connected thereto.

[0043] One or more of the various sensors and signals of the system 200 may be used by the controller 214 to support the organ 50, and thus the patient 54, within the system 200 in an automated or semi-automated manner, such as to help reduce the time and effort required to support the organ 50. The controller 214 may use various algorithms (e.g., PID loops) incorporating data from one or more sensors to effect such growth or maintenance of the organ. Various examples are described in further detail below.

[0044] In one embodiment, the controller 214 may be configured to receive an inlet temperature signal from the inlet sensors 238a or an outlet temperature signal from the outlet sensors 238b. The controller 214 may further be configured to operate the pump 206, the gas transfer unit 208, or the heating and cooling system 210 based on the temperature signal. For example, the controller 214 may activate cooling of the system 210 when the outlet temperature signal indicates that the temperature of the blood in the circuit 204 is above a threshold, such as 37, 38, or 39 degrees Celsius. Similarly, the controller 214 may activate heating of the system 210 when the outlet temperature signal indicates that the temperature of the blood in the circuit 204 is below a threshold, such as 37, 36, or 35 degrees Celsius. This control may help ensure that the fluid entering the patient 54 is at an acceptable level, as well as for the organ 50. In some embodiments, the controller 214 may modify the operation of such components based on an ambient temperature signal from an ambient temperature sensor. The controller 214 may also be configured to generate an alert based on any of the temperature sensor signals.

[0045] In another embodiment, the controller 214 may be configured to receive a glucose sensor signal from a glucose sensor (such as the inlet sensor group 238a or the outlet sensor group 238b), and the controller 214 may be configured to activate the pump 206, the gas transfer unit 208, or the infusion system 216 based on the glucose sensor signal. For example, if the glucose concentration of the blood in the circuit 204 drops below a threshold (e.g., 0.5 grams per liter), the controller 214 may activate the glucose infusion pump 230 to infuse glucose into the blood circuit 204. The controller 214 may use one or more glucose sensor signals to determine a glucose consumption rate of the organ 50 or the patient 54. The controller 214 may also be configured to adjust the glucose infusion based on consumption, or generate an alert based on glucose consumption, such as if the glucose consumption rate of the organ 50 or the patient 54 drops below a threshold (e.g., 100 milligrams per hour).

[0046] In another embodiment, the controller 214 may be configured to receive a pressure signal from a pressure sensor (such as the sensor group 238 or 240), and the controller 214 may be configured to operate the pumps 206a, 206b, 206c, or the cooling system 210 based on the pressure signal. The controller 214 may also be configured to generate an alert based on the pressure signal, such as if the pressure drops below a threshold pressure and the pump is operating, indicating that the pump is or has been damaged. The pumps 206 may be controlled to vary the flow rate of blood through the blood circuit 204, such as from 0 to 2300 milliliters per minute (ml / min). Optionally, the pumps 206a and 206b may operate at 0 to 150 ml / min and the pump 206c may operate at approximately 1000 ml / min, such as to provide a higher flow rate in the secondary circuit 212a. The pumps 206 may also be controlled to vary the operating pressure, such as from 0 to 200 millimeters of mercury (mm / Hg). The flow of the pump 206 may be controlled based on the monitored pressure in the secondary circuit 212a or the primary circuit 212b.

[0047] For example, the controller 214 may monitor the flow and pressure through the secondary circuit 212a using one or more of the inlet sensors 238a or the outlet sensors 238b and may adjust the flow of one or more of the pumps 206 based on the pressure or flow signal, such as to maintain a desired pressure or flow rate through the organ 50. Similarly, the controller 214 may monitor the flow and pressure through the primary circuit 212b using one or more of the secondary inlet sensors 246a and the secondary outlet sensors 246b and may adjust the flow of one or more of the pumps 206 based on the pressure or flow signal, such as to maintain a desired pressure or flow rate through the patient 54 or to match the patient's flow rate or fluid pressure.

[0048] In another embodiment, the controller 214 may be configured to receive a gas signal from a gas sensor (such as the inlet sensor group 238a or the outlet sensor group 238b) and may use the gas signal (e.g., O2 or CO2) to determine the gas consumption of the organ 50 based on the gas signal. The controller 214 may also activate the gas transfer unit 208 or the gas tank 222 based on the determined gas consumption of the organ 50 or may generate an alert based on the determined consumption. Similarly, the controller 214 may be configured to receive a gas signal from a gas sensor (such as the secondary inlet sensor group 246a or the secondary outlet sensor group 246b) and may use the gas signal (e.g., O2 or CO2) to determine the gas consumption of the patient 54 based on the gas signal. The controller 214 may also activate the gas transfer unit 208 or the gas tank 222 based on the determined gas consumption of the patient 54 or may generate an alert based on the determined consumption. The controller 214 may also operate the infusion system 216 based on the gas signal. For example, the controller 214 may infuse one or more solutions based on the consumption rate of the patient 54 or organ 50.

[0049] In another embodiment, the controller 214 may be configured to receive a pH signal from a pH sensor (such as the inlet sensor group 238a or the outlet sensor group 238b) and may use the pH signal to determine the pH range of the blood in the secondary circuit 212a. The controller 214 may operate one or more of the pumps 230 of the infusion system 216 to provide one or more fluids to the blood circuit 204 to maintain the pH within a desired or operable range. Similarly, the controller 214 may be configured to receive a pH signal from a pH sensor of the secondary inlet sensor group 246a or the secondary outlet sensor group 246b and may use the pH signal to determine the pH range of the blood in the primary circuit 212b. The controller 214 may operate one or more of the pumps 230 of the infusion system 216 to provide one or more fluids to the blood circuit 204 to maintain the pH within a desired or operable range. The controller 214 may also be configured to generate an alert based on the pH signal, such as if the pH level in the blood circuit 204 falls outside an acceptable range. In such an embodiment, the alert may indicate that the organ 50 has been contaminated or damaged, or that the organ of the patient 54 is not functioning as it should.

[0050] The controller 214 may be in communication with the air bubble sensors 234, 242, and 252, and may be configured to receive an air bubble sensor signal from each based on the detection of an air bubble in the blood circuit 204. The controller 214 may shut down one or more of the pumps when an air bubble is detected in the circuit. Optionally, the controller 214 may shut down only some of the pumps when an air bubble is detected. For example, pumps 206a and 206b may be shut down when an air bubble is detected at sensor 242 or 252, but pump 206c may continue to operate, such as to continue supporting the organ 50.

[0051] In another embodiment, the controller 214 may be configured to receive an organ health sensor signal from an organ health sensor (such as the inlet sensors 238a, the outlet sensors 238b, the secondary inlet sensors 246a, or the secondary outlet sensors 246b), and the controller 214 may be configured to operate the pump 206 and the gas transfer unit 208 based on the organ health sensor signal. Optionally, the controller 214 may operate the infusion system 216 to operate one or more of the pumps 230 to pump fluid from one or more of the reservoirs 232 to the blood circuit 204 based on the signal from the organ health sensor. The controller 214 may also be configured to generate an alert based on the organ health sensor signal. In some embodiments, the organ health sensor may be one or more metabolite sensors.

[0052] The controller 214 may operate the pump 230 to infuse one or more nutrients into the blood circuit 204 to maintain desired metabolite levels in the organ 50, the patient 54, and the blood circuit 204. The organ health sensor may be various types of sensors configured to monitor one or more conditions of the blood. For example, the organ health sensor may be an ammonia sensor configured to generate a signal based on a concentration or level of ammonia in the blood. The organ health sensor may also be a glutamine sensor configured to generate a signal based on a concentration or level of glutamine in the blood. The organ health sensor may also be a lactate sensor configured to generate a signal based on a concentration or level of lactate in the blood. The organ health sensor may also be a bile sensor configured to generate a signal based on a concentration or level of bile in the blood. The organ health sensor may also be a creatinine sensor configured to generate a signal based on a concentration or level of creatinine in the blood. The organ health sensor may also be an albumin sensor configured to generate a signal based on a concentration or level of albumin in the blood. The organ health sensor may also be a clotting time sensor to generate a signal based on the activated clotting time (ACT) of the blood. Clotting factors (such as Factor VII, Factor VIII, or Factor X) may also be monitored in the blood, blood, or medium. In some embodiments, the controller 214 may be configured to receive the health signal from the health sensor and to control the infusion of an anticoagulant (such as heparin) if the ACT falls below a threshold (such as below 100 seconds).

[0053] In some embodiments, a sampling port 240a may be used to remove a sample volume from the blood circuit. The sample may be manually tested or the sample may be automatically tested for in-transit sampling and analysis. The sample collected from the sampling port 240a may be used by the controller 214 to add biochemical components necessary for the development and maintenance of function of the organ 50 or the organ of the patient 54 through the infusion system 216. Additionally, automatic sampling of subsystems may be performed by the controller 214. For example, blood may be automatically drawn from the system and delivered to components that measure ACT, glucose, lactate, ammonia, or the like.

[0054] In some embodiments, a blood or medium sample may be taken through sampling port 240a (or using a glucose sensor in secondary sensor group 238a). The sample may be assayed (e.g., by controller 214) for blood glucose content over a specified period of time. This may be done to determine if the organ 50 or patient 54 has a sufficient glucose consumption rate. When it is determined that the glucose level of the blood in circuit 204 is too low, controller 214 may activate infusion system 216 to infuse glucose into circuit 204 to help maintain the organ 50 and the organs of patient 54. In some embodiments, multiple samples from multiple sampling ports (e.g., sampling port 240a and sample port 248a) may be used to determine which organs are performing suboptimally.

[0055] In some embodiments, a specified dose of a drug that is generally cleared by the organ may be infused for a specified period of time (e.g., (R)-warfarin, (S)-mephenytoin, acetaminophen, aprepitant, azoles, benzodiazepines, beta, caffeine, calcium, carbamazepine, celecoxib, clarithromycin, codeine, cyclosporine, delavirdine, dextromethorphan, diazepam, diclofenac, enalapril, erythromycin, estradiol, estrogen, fentanyl, finasteride, flecainide, fluoxetine, glipizide, glyburide, haloperidol, indinavir, indomethacin, naphthalene, isopropyl alcohol ... Methacin, Lidocaine, Lopinavir, Loratidine, Methadone, Mexiletine, Morphine, Nelfinavir, Nifedipine, Olanzapine, Omeprazole, Opioids, Pentamidine, Phenothiazines, Phenytoin, Piroxicam, Prednisone, Progesterone, Propranolol, Quinidine, Risperidone, Ritonavir, Selective Serotonin Reuptake Inhibitors, Saquinavir, Sildenafil, Sirolimus, Statins, Tacrine, Tacrolimus, Tamoxifen, Testosterone, Theophylline, Tramadol, Trazodone, Tricyclics, Valproate, Venlafaxine, Verapamil, or Voriconazole. Blood or culture medium samples may be taken periodically from sampling port 240a and bioanalyzed to determine if the liver BEO (organ 50) is clearing the drug at a sufficient rate. In some embodiments, blood or medium samples may be taken from sampling port 240a over a specified time period and assayed for albumin content to determine if the hepatic BEO has sufficient albumin production. In some embodiments, blood or medium samples may be taken from sampling port 240a over a specified time period and assayed for bile content to determine if the hepatic BEO has sufficient bile production.In some embodiments, blood or medium samples may be taken from sampling port 240a over a specified period of time and assayed for creatinine, BSA, and / or urea content to determine whether the renal BEO (organ 50) has a glomerular filtration rate, which is indicative of normal function or activity of the organ.

[0056] FIG. 4 illustrates a schematic diagram of a method 400 according to at least one embodiment of the present disclosure. Method 400 may be a method of testing and supporting a BEO and a patient. The steps or operations of method 400 are illustrated in a particular order for convenience and clarity; many of the operations discussed may be performed in a different sequence or in parallel without significantly affecting other operations. Method 400 discussed herein includes operations performed by multiple different actors, devices, and / or systems. It is understood that a subset of the operations discussed in method 400 may be attributable to a single actor, device, or system and may be considered a separate, stand-alone process or method.

[0057] The method 400 begins at step 402, where an organ may be housed in an enclosure including a blood inlet and a blood outlet connected to a secondary loop of the system. For example, the organ 50 may be housed in the enclosure 202 connected to the secondary circuit 212a. At step 404, the primary loop of the system may be connected to a patient, the primary loop being connected to the secondary loop. For example, the primary circuit 212b of the system 200 may be connected to the patient 54. At step 406, blood may be pumped through the primary loop using a primary pump to pump the blood through the patient. For example, blood may be pumped through the primary circuit 212b using pumps 206a and 206b to pump the blood through the patient 54. At step 406, blood may also be pumped through the secondary loop using a secondary pump, where the secondary pump may be connected to a blood inlet and a blood outlet to pump the blood through the organ and the primary loop. For example, blood may be pumped through the secondary circuit 212a using pump 206c to move the blood through the organ and the secondary circuit 212a.

[0058] At step 408, gas may be transferred to or from the blood using a gas transfer unit connected to the blood circuit. For example, gas may be transferred to or from the blood of the blood circuit 204 using the gas transfer unit 208. At step 410, the blood of the circuit 204 may be warmed. At step 412, a sensor signal indicative of the condition of the blood may be received. For example, the controller 214 may receive a signal from one or more sensors of the inlet sensor group 238a, the outlet sensor group 238b, the secondary inlet sensor group 246a, or the secondary outlet sensor group 246b. At step 414, a pump and an infusion system may be activated based on the one or more sensor signals.

[0059] In another embodiment, nutrients may be injected into the system using an injection system connected to the secondary circuit, for example, nutrients may be injected into the system 200 using injection system 216 connected to the secondary circuit 212a.

[0060] FIG. 5 illustrates a block diagram of an example machine 500 on which any one or more of the techniques (e.g., methodologies) discussed herein may be performed. An embodiment as described herein may include or be operated by logic or some components or mechanisms within the machine 500 (which may be the system 200). Circuitry (e.g., processing circuitry) is a collection of circuits implemented in the tangible entity of the machine 500, including hardware (e.g., simple circuits, gates, logic, etc.). The membership of a circuitry may be flexible over time. A circuitry includes members that may perform designated operations alone or in combination when operated. In one embodiment, the hardware of the circuitry may be invariably designed (e.g., hardwired, etc.) to perform a particular operation. In one embodiment, the hardware of the circuitry may include variably connected physical components (e.g., execution units, transistors, simple circuits, etc.) that also include machine-readable media that are physically modified (e.g., magnetically, electrically movable arrangements of immutable mass particles, etc.) to encode instructions for a particular operation. In connecting the physical components, the underlying electrical properties of the hardware components are changed, such as from an insulator to a conductor, or vice versa. The instructions enable the embedded hardware (e.g., execution units or loading mechanisms) to create members of the circuitry in the hardware through the variable connections to perform a portion of a particular operation when operated. Thus, in one embodiment, during operation of the device, the machine-readable media elements are part of the circuitry or are communicatively coupled to other components of the circuitry. In one embodiment, any of the physical components may be used in more than one member of more than one circuitry. For example, in operation, an execution unit may be used in a first circuit of a first circuitry at one time and reused at a different time by a second circuit in the first circuitry, or by a third circuit in the second circuitry. Further examples of these components with respect to machine 500 are provided below.

[0061] In alternative embodiments, the machine 500 may operate as a standalone device or may be connected (e.g., networked) to other machines. In a networked deployment, the machine 500 may operate in the capacity of a server machine, a client machine, or both in a server-client network environment. In one embodiment, the machine 500 may act as a peer machine in a peer-to-peer (P2P) (or other distributed) network environment. The machine 500 may be a personal computer (PC), a tablet PC, a set-top box (STB), a personal digital assistant (PDA), a mobile phone, a web appliance, a network router, switch or bridge, or any machine capable of executing instructions (sequential or otherwise) that specify actions that the machine should take. Additionally, although only a single machine is illustrated, the term "machine" should also be construed to include any collection of machines that individually or jointly execute an instruction set (or multiple instruction sets) to perform any one or more of the methodologies discussed herein, such as cloud computing, software as a service (SaaS), other computer cluster configurations, etc.

[0062] The machine (e.g., computer system) 500 may include a hardware processor 502 (e.g., a central processing unit (CPU), a graphics processing unit (GPU), a hardware processor core, or any combination thereof), a main memory 504, a static memory (e.g., memory or storage for firmware, microcode, basic input / output (BIOS), Unified Extensible Firmware Interface (UEFI), etc.) 506, and mass storage 508 (e.g., hard drives, tape drives, flash storage, or other block devices), some or all of which may be in communication with each other via an interlink (e.g., bus) 530. The machine 500 may further include a display unit 510, an alphanumeric input device 512 (e.g., a keyboard), and a user interface (UI) navigation device 514 (e.g., a mouse). In one embodiment, the display unit 510, the input device 512, and the UI navigation device 514 may be touch screen displays. The machine 500 may additionally include a storage device (e.g., a drive unit) 508; a signal generating device 518 (e.g., a speaker); a network interface device 520; and one or more sensors 516, such as a Global Positioning System (GPS) sensor, a compass, an accelerometer, or other sensor. The machine 500 may include an output controller 528, such as a serial connection (e.g., Universal Serial Bus (USB)), a parallel connection, or other wired or wireless connection (e.g., infrared (IR), near field communication (NFC), etc.), to communicate with or control one or more peripheral devices (e.g., a printer, a card reader, etc.).

[0063] The processor 502, the main memory 504, the static memory 506, or the registers of the mass storage 508 may be or include a machine-readable medium 522 on which is stored one or more sets of data structures or instructions 524 (e.g., software) that embody or are utilized by any one or more of the techniques or functions described herein. The instructions 524 may also reside, completely or at least partially, within a register of the processor 502, the main memory 504, the static memory 506, or the mass storage 508 during execution by the machine 500. In one embodiment, one of the hardware processor 502, the main memory 504, the static memory 506, or the mass storage 508, or any combination thereof, may constitute the machine-readable medium 522. Although the machine-readable medium 522 is illustrated as a single medium, the term “machine-readable medium” may include a single medium or multiple media (e.g., a centralized or distributed database and / or associated caches and servers) configured to store one or more instructions 524.

[0064] The term "machine-readable medium" may include any medium capable of storing, encoding, or carrying instructions that are executed by the machine 500 and cause the machine 500 to perform one or more of the techniques of this disclosure; or any medium capable of storing, encoding, or carrying data structures used by or related to such instructions. Non-limiting examples of machine-readable media may include solid-state memory, optical media, magnetic media, and signals (e.g., radio frequency signals, other photon-based signals, acoustic signals, etc.). In one embodiment, a non-transient machine-readable medium comprises a machine-readable medium with a plurality of particles that have a fixed (e.g., stationary) mass and are therefore a composition of matter. Thus, a non-transient machine-readable medium is a machine-readable medium that does not include a transitory propagating signal. Examples of non-transitory machine-readable media may include non-volatile memory, such as semiconductor memory devices (e.g., electrically programmable read-only memory (EPROM), electrically erasable programmable read-only memory (EEPROM)) and flash memory devices; magnetic disks, such as internal hard disks and removable disks; magneto-optical disks; and CD-ROM and DVD-ROM disks.

[0065] The instructions 524 may further be transmitted or received over a communications network 526 using a transmission medium via a network interface device 520 utilizing any one of a number of transport protocols (e.g., Frame Relay, Internet Protocol (IP), Transmission Control Protocol (TCP), User Datagram Protocol (UDP), Hypertext Transfer Protocol (HTTP), etc.). Examples of communications networks may include local area networks (LANs), wide area networks (WANs), packet data networks (e.g., the Internet), mobile telephone networks (e.g., cellular networks), plain old telephone (POTS) networks, as well as wireless data networks (e.g., the Institute of Electrical and Electronics Engineers (IEEE) 802.11 family of standards known as Wi-Fi®, the IEEE 802.16 family of standards known as WiMax®), the IEEE 802.15.4 family of standards, peer-to-peer (P2P) networks, etc., among others. In one embodiment, the network interface device 520 may include one or more physical jacks (e.g., Ethernet, coaxial, or telephone jacks) or one or more antennas for connecting to the communications network 526. In one embodiment, the network interface device 520 may include multiple antennas for wireless communication using at least one of single-input multiple-output (SIMO), multiple-input multiple-output (MIMO), or multiple-input single-output (MISO) techniques. The term "transmission medium" should be taken to include any intangible medium capable of storing, encoding, or carrying instructions for execution by the machine 500, including digital or analog communication signals or other intangible media for facilitating communication of such software. Transmission media are machine-readable media.

[0066] 6 illustrates a schematic diagram of a system 600 for the growth and support of bioengineered organs. System 600 may be similar to system 200 described above; system 600 may include additional features or components, such as a storage container and a purge line. Any of the systems described above or below may be modified to include the features of system 600. Components in system 600 with similar numbering as system 200 may refer to similar components that may be connected and operated as described above.

[0067] More specifically, the system 600 may include a storage container 656. The storage container 656 may be connected to the blood circuit 604 downstream of the enclosure 602, and may be independently or separately connected downstream of the organ 50, such as to one or more vessels of the organ 50. In this manner, blood flowing from a drain of the enclosure 602 and through the organ 50 may be reintroduced into the circuit via the storage container 656.

[0068] The drain of the enclosure 602 may be gravity fed and thus connected to the bottom of the enclosure 602 and the top of the storage container 656. This setup allows the storage container 656 to help maintain a desired volume of blood in the enclosure 602. Because the storage container 656 may be smaller (or may be a different shape) compared to the enclosure 602, the storage container 656 may create a smaller surface area for air to blood contact in the storage container 656 compared to the enclosure 602. Thus, the storage container 656 keeps the volume of blood in the enclosure 602 small, which may help limit air exposure of the blood. The blood outlet 602b from the organ 50 may be connected to the bottom or other part of the storage container 656 and may be driven to flow by one or more of the primary pump 606a and the secondary pump 606c.

[0069] The system 600 may also include a weight sensor 613a connected to the enclosure 602, similar to the sensor 213 described above. The system 600 may further include a weight sensor 613b connected to the storage container 656. The weight sensor 613b may be in communication with the controller 614, such as to send a weight signal thereto. The controller 614 may determine a weight or volume of the fluid in the storage container 656 and, optionally, control various components of the system, such as the pump 606, based on that weight or volume. This allows the controller 614 to target a specific volume or weight of the storage container 656, which helps limit overfilling or depletion of the fluid (e.g., blood) in the storage container 656.

[0070] The output of the storage container 656 may be connected upstream or to the inlet of both the primary pump 606a and the secondary pump 606c so that the storage container 656 can provide a buffer volume of blood or fluid to either the primary pump 606a or the secondary pump 606c. The pumps 606a and 606b may each be in communication with the controller 614 so that the controller 614 can operate the primary pump 606a and the second primary pump 606b (which may be in series with each other but on opposite sides of the patient 54) to prevent a net zero blood volume entering or leaving the patient during cleaning operations of the system 600.

[0071] The system 600 may include a filter 658 located at least partially within the storage container 656. The filter 658 may be configured to filter impurities, clots, or contaminants from the blood as it passes through the storage container 656. For example, the filter 658 may be located between an inlet from the enclosure 602 and organ 50 and an outlet connected to the pumps 606a and 606c.

[0072] FIG. 6 also shows that the system 600 may include a purge line 660 connected to the gas transfer unit 608 and to the storage container 656. The purge line 660 may be configured to direct blood from the gas transfer unit 608 during a flushing or purging sequence, such as during a portion of a start-up sequence. The purge line 660 may help carry gases, such as oxygen, trapped within the blood volume portion of the gas transfer unit 608 from the gas transfer unit 608 into the storage container 656 to allow the gas to be vented from the system 600 or to collect in the storage container 656. This process may help ensure that the blood volume of the gas transfer unit 608 is primed with blood, which helps limit the opportunity for air bubbles to get into the circuit. A purge valve 662 may be connected to the purge line 660 and may be in communication with the controller 614. The controller 614 may operate the purge valve 662 to control flow through the purge line 660 during a purge sequence, and may help prevent blood from flowing through the purge line 660 during normal operation, such as by closing the purge valve 662 during normal operation when the organ 50 and patient 54 are supported.

[0073] The system 600 may also include one or more tube clamps 664 connected to the primary circuit 612b, such as for connecting and disconnecting the patient 54 from the primary circuit 612b.

[0074] When the system 600 is connected to a patient, the system 600 may be configured to support multiple types of organs within the enclosure 602, thereby supporting the patient 54. For example, the system 600 may be configured to support the liver of the patient 54, such that the organ 50 is a liver and the primary circuit 612b is connected to the liver of the patient 54. In such an embodiment, the system 600 may be configured to support and monitor the patient's liver, such as with the organ 50 acting to perform the functions of the liver instead of or in support of the liver of the patient 54. For example, the liver 50 may process ammonia, lipids, or glucose.

[0075] For example, ammonia levels in the secondary circuit 612a and the primary circuit 612b may be monitored, such as via inlet sensors 638a, which may be in communication with the controller 614, as the organ 50 helps support or monitor hepatic ammonia clearance or removal in the patient 54. The sensors may send an ammonia sensor signal to the controller 614, which may use the signal to determine the amount of ammonia in the blood in the circuit. The controller 614 may operate the gas transfer unit 608, the infusion system 616, and one or more pumps based on the detected or determined amount of ammonia in the system 600.

[0076] Similarly, inlet sensor group 638a may include one or more sensors to enable controller 614 to determine a prothrombin time (PT) or an international normalized ratio (INR), and controller 614 may operate gas transfer unit 608, infusion system 616, and one or more pumps based on the detected or determined PT or INR in system 600 or of patient 54.

[0077] System 600 may also include sensors for determining or detecting levels of albumin, urea, cholesterol, or protein to determine an overall condition of system 600 or patient 54, or to detect or determine specific conditions that may be indicative of liver health or performance. Controller 614 may operate gas transfer unit 608, infusion system 616, and one or more pumps based on the detected or determined conditions within system 600.

[0078] During conditioning or support of the liver in patient 54, controller 614 may operate second primary pump 606b at a rate of 0-300 milliliters per minute (ml / min) on pump 1 and control secondary pump 606c at a rate of 200-2000 ml / min.

[0079] System 600 may also be configured to support other organs of the patient, such as the kidney, pancreas, spleen, or heart. For example, when organ 50 is a bioengineered kidney and system 600 is connected to the patient's kidney, system 600 may detect or determine renal indicators, such as creatinine, blood urea nitrogen (BUN), albumin, or other proteins, and controller 614 may operate gas transfer unit 608, infusion system 616, and one or more pumps based on the detected or determined renal condition in system 600. EXAMPLES

[0080] Notes and Examples The following non-limiting examples detail particular aspects of the present subject matter that, among other things, solve the problems and provide the benefits discussed herein.

[0081] Example 1 is a system for supporting a patient organ, comprising: a primary circuit including an inlet configured to connect to the patient and an outlet configured to connect to the patient, the primary circuit comprising a primary pump configured to circulate blood through the primary circuit and into the patient; a secondary circuit connected to the primary blood circuit, an enclosure configured to support an organ therein in a blood flow, the enclosure including a blood inlet and a blood outlet for receiving the blood flow through the enclosure and through the organ; a secondary pump configured to circulate blood through the secondary circuit; a gas transfer unit configured to transfer gas to and from the blood; a secondary sensor connected upstream of the enclosure and configured to generate a secondary sensor signal based on the condition of the blood; and a secondary circuit comprising: A controller configured to operate the gas transfer unit based on the secondary sensor signal.

[0082] In Example 2, the subject matter of Example 1 optionally includes: a bypass circuit connected to the primary circuit and the secondary circuit, the bypass circuit; and A second primary pump located downstream of the patient and configured to circulate blood through the primary circuit and from the patient.

[0083] In Example 3, the subject matter of any one or more of Examples 1-2 optionally includes: a secondary circuit comprising a port upstream of the enclosure for sampling blood.

[0084] In Example 4, the subject matter of any one or more of Examples 1-3 optionally includes: a gas mixing unit connected to the gas transfer unit and configured to deliver gas to the gas transfer unit.

[0085] In example 5, the subject matter of example 4 optionally includes: The secondary sensor is a pressure transducer configured to send a pressure signal to the controller based on the pressure of the blood; and a temperature sensor configured to send a temperature signal to the controller based on a temperature of the blood. wherein the controller operates a gas transfer unit, a primary pump, and a secondary pump based on the pressure signal and the temperature signal.

[0086] In example 6, the subject matter of example 5 optionally includes: an inlet dissolved oxygen sensor upstream of the enclosure and configured to send an inlet oxygen signal to the controller based on an inlet dissolved oxygen level of the blood; and an outlet dissolved oxygen sensor downstream of the enclosure and configured to send an outlet oxygen signal to the controller based on an outlet dissolved oxygen level of the blood. A secondary circuit comprising:

[0087] In Example 7, the subject matter of Example 6 optionally includes: the controller being configured to determine an oxygen usage rate of the organ based on the inlet oxygen signal and the outlet oxygen signal; and the controller being configured to operate the gas transfer unit, the primary pump, and the secondary pump based on the oxygen usage rate of the organ.

[0088] In Example 8, the subject matter of Example 7 optionally includes: the controller being configured to determine an oxygen usage rate of the patient's organ based on the inlet oxygen signal and the outlet oxygen signal; and the controller being configured to operate the gas transfer unit, the primary pump, and the secondary pump based on the oxygen usage rate of the patient's organ.

[0089] In Example 9, the subject matter of any one or more of Examples 2-8 optionally includes: a secondary circuit comprising a bubble trap and a bubble sensor upstream of the gas transfer unit.

[0090] In Example 10, the subject matter of any one or more of Examples 1-9 optionally includes: the gas transfer unit is an oxygenator.

[0091] In Example 11, the subject matter of example 10 optionally includes: the gas transfer unit includes an air separator.

[0092] In Example 12, the subject matter of any one or more of Examples 2-11 optionally includes: a warming system connected to the gas transfer unit for exchanging heat with the blood through the gas transfer unit.

[0093] In Example 13, the subject matter of any one or more of Examples 1-12 optionally includes: an infusion system connected to a secondary circuit upstream of the enclosure and in communication with a controller, the controller configured to operate the infusion system based on a sensor signal to deliver a nutritional supplement to the blood.

[0094] In Example 14, the subject matter of Example 13 optionally includes: the infusion system includes a plurality of infusion pumps, each configured to deliver a nutritional supplement to the blood; and the controller is configured to operate each of the infusion pumps based on the secondary sensor signal to deliver the nutritional supplement to the blood.

[0095] In Example 15, the subject matter of Example 14 optionally includes: S), sodium bicarbonate, insulin, epinephrine, albumin, linoleic acid, dexamethasone, and glucagon.

[0096] In Example 16, the subject matter of the undefined embodiment optionally includes: the infusion system includes an enclosure supporting the plurality of infusion pumps and the nutritional supplement.

[0097] In Example 17, the subject matter of Example 16 optionally includes: the injection system includes a cooling system configured to cool an environment of the injection system; the cooling system is in communication with a controller; and the controller is configured to operate the cooling system to maintain a desired temperature of the environment of the injection system.

[0098] In Example 18, the subject matter of the undefined embodiments optionally includes: further comprising a storage container connected to the outflow of the enclosure and connectable to the outflow of the organ's vasculature, the storage container being located upstream of the secondary pump and the primary pump.

[0099] In Example 19, the subject matter of Example 18 optionally includes: a filter located at least partially within the storage container and configured to filter perfusate passing through the storage container.

[0100] In Example 20, the subject matter of any one or more of Examples 18-19 optionally includes: a purge line connected to the gas transfer unit and connected to the storage container.

[0101] Example 21 is a method for growing or supporting an organ using the system, comprising the steps of: housing the organ in an enclosure including a blood inlet and a blood outlet connected to a secondary loop of the system; connecting a primary loop of the system to a patient, the primary loop being connected to the secondary loop; pumping blood through the primary loop using a primary pump to deliver the blood through the patient; pumping blood through the secondary loop using a secondary pump, the secondary pump connected to the blood inlet and the blood outlet for pumping blood through the organ and the secondary loop; transferring gas to or from the blood using a gas transfer unit connected to a blood circuit including the primary loop and the secondary loop; receiving a sensor signal indicative of a condition of the blood; and Activating the pump system based on the sensor signal.

[0102] In Example 22, the subject matter of example 21 optionally includes: injecting nutrients into the system using an injection system connected to the secondary circuit.

[0103] In Example 23, the subject matter of Example 22, optionally including: injecting nutrients based on the sensor signal.

[0104] In Example 23, the subject matter of example 21 optionally includes: operating a gas mixing unit to deliver gas to the gas transfer unit.

[0105] In Example 24, the subject matter of Example 23 optionally includes: the gas mixing unit delivering one or more of carbon dioxide, dioxygen, nitrogen, or argon to the gas transfer unit based on the sensor signal.

[0106] In Example 25, the subject matter of any one or more of Examples 18-20 optionally includes: injecting nutrients into the system using an injection system connected to the secondary circuit.

[0107] Example 26 is at least one machine-readable medium comprising instructions that, when executed by a processing circuitry, cause the processing circuitry to perform operations to implement any of Examples 1-25.

[0108] Example 27 is an apparatus having means for carrying out any one of Examples 1 to 25.

[0109] Example 28 is a system for carrying out any one of Examples 1 to 25.

[0110] Example 29 is a method for carrying out any of Examples 1-25.

[0111] In Example 30, the apparatus or method of any one or any combination of Examples 1 to 29 may be optionally configured such that all recited elements or options are available for use or selection therein.

[0112] The above detailed description includes references to the accompanying drawings, which form a part of the detailed description. The drawings show, by way of illustration, specific embodiments in which the invention may be practiced. These embodiments are also referred to herein as "examples." Such embodiments may include elements in addition to those shown and described. However, the inventors also contemplate embodiments in which only those elements shown or described are provided. Moreover, the inventors also contemplate embodiments using any combination or permutation of the elements shown or described (or one or more aspects thereof), either with respect to the particular embodiment (or one or more aspects thereof) or other embodiments (or one or more aspects thereof) shown or described herein.

[0113] In the event of a conflict of language between this document and any document incorporated by reference, the language in this document will control. In this document, the terms "including" and "in which" are used as the plain English equivalents of the respective terms "comprising" and "wherein." And also, in the appended claims, the terms "including" and "comprising" are open-ended; that is, a system, device, article, composition, formulation, or process that includes elements in addition to the elements recited after such term in a claim is also deemed to be within the scope of that claim.

[0114] In this document, the terms "a" or "an" are used, as is common in patent documents, to include one or more, independent of any other instance or the usage of "at least one" or "one or more." In this document, the term "or" is used to refer to a non-exclusive or, so that "A or B" includes "A but not B," "B but not A," and "A and B," unless otherwise indicated. In this document, the terms "including" and "in which" are used as the plain English equivalents of the respective terms "comprising" and "wherein." Also, in the appended claims, the terms "comprising" and "comprising" are open-ended; that is, systems, devices, articles, compositions, formulations, or processes that include elements in addition to the elements recited after such a term in a claim are also considered to be within the scope of the claim. Moreover, in the appended claims, the terms "first," "second," and "third," etc. are used merely as labels and are not intended to impose numerical requirements thereon.

[0115] The above description is intended to be illustrative, not restrictive. For example, the above-described embodiments (or one or more aspects thereof) may be used in combination with each other. Other embodiments may be used by one of ordinary skill in the art upon review of the above description. The Abstract is provided in accordance with 37 CFR §1.72(b) to enable the reader to quickly ascertain the nature of the technical disclosure, and is submitted with the understanding that it will not be used to interpret or limit the scope or meaning of the claims. Also, in the above detailed description, various features may be grouped together to simplify the disclosure. This should not be construed as intending that an unclaimed disclosed feature is essential to any claim. Rather, inventive subject matter may exist in less than all features of a particular disclosed embodiment. Thus, it is contemplated that the appended claims are incorporated into the detailed description herein as an example or embodiment, with each claim standing on its own as a separate embodiment, and that such embodiments may be combined with each other in various combinations or permutations. The scope of the invention should be determined with reference to the appended claims, along with the full scope of equivalents to which such claims are entitled.

Claims

1. 1. A system for supporting a patient organ, comprising: a primary circuit including an inlet configured to connect to the patient and an outlet configured to connect to the patient, the primary circuit comprising a primary pump configured to circulate blood through the primary circuit and into the patient; a secondary circuit connected to the primary blood circuit, an enclosure configured to support an organ therein in a blood flow, the enclosure including a blood inlet and a blood outlet for receiving the blood flow through the enclosure and through the organ; a secondary pump configured to circulate blood through the secondary circuit; a gas transfer unit configured to transfer gas to and from the blood; a secondary sensor connected upstream of the enclosure and configured to generate a secondary sensor signal based on the condition of the blood; and a secondary circuit comprising: A controller configured to operate the gas transfer unit based on the secondary sensor signal.

2. a bypass circuit connected to the primary circuit and the secondary circuit, the bypass circuit; and a second primary pump downstream of the patient and configured to circulate blood through the primary circuit and from the patient; The system of claim 1 , further comprising:

3. The secondary circuit is A port upstream of the enclosure for sampling blood 2. The system of claim 1, comprising:

4. a gas mixing unit connected to the gas transfer unit and configured to deliver gas to the gas transfer unit; The system of claim 1 , further comprising:

5. The secondary sensor is a pressure transducer configured to send a pressure signal to the controller based on the pressure of the blood; and a temperature sensor configured to send a temperature signal to the controller based on a temperature of the blood. wherein the controller operates a gas transfer unit, a primary pump, and a secondary pump based on the pressure signal and the temperature signal.

5. The system of claim 4.

6. The secondary circuit is an inlet dissolved oxygen sensor upstream of the enclosure and configured to send an inlet oxygen signal to the controller based on an inlet dissolved oxygen level of the blood; and an outlet dissolved oxygen sensor downstream of the enclosure and configured to send an outlet oxygen signal to the controller based on an outlet dissolved oxygen level of the blood.

6. The system of claim 5, comprising:

7. 7. The system of claim 6, wherein the controller is configured to determine an oxygen utilization rate of the organ based on the inlet oxygen signal and the outlet oxygen signal, and the controller is configured to operate the gas transfer unit, the primary pump, and the secondary pump based on the oxygen utilization rate of the organ.

8. 8. The system of claim 7, wherein the controller is configured to determine an oxygen utilization rate of the patient's organ based on the inlet oxygen signal and the outlet oxygen signal, and the controller is configured to operate the gas transfer unit, the primary pump, and the secondary pump based on the oxygen utilization rate of the patient's organ.

9. The secondary circuit is Air bubble traps and air bubble sensors upstream of the gas transfer unit 3. The system of claim 2, comprising:

10. 10. The system of claim 1, wherein the gas transfer unit is an oxygenator.

11. 11. The system of claim 10, wherein the gas transfer unit comprises an air separator.

12. a warming system connected to the gas transfer unit for exchanging heat with the blood through the gas transfer unit; 3. The system of claim 2, further comprising:

13. an infusion system connected to the secondary circuit upstream of the enclosure and in communication with a controller, the controller configured to operate the infusion system based on the sensor signal to deliver a nutritional supplement to the blood. The system of claim 1 , further comprising:

14. 14. The system of claim 13, wherein the infusion system includes a plurality of infusion pumps, each configured to deliver a nutritional supplement to the blood; and the controller is configured to operate each of the infusion pumps based on the secondary sensor signal to deliver a nutritional supplement to the blood.

15. Multiple infusion pumps can deliver cell culture media, cells, glutamine, glucose, buffers, sodium chloride, essential amino acids, non-essential amino acids, drugs, ammonia (ammonium chloride), HEPES (C 8 H 18 N 2 O 4 15. The system of claim 14, configured to deliver one or more of the following to the blood and organs, respectively: S), sodium bicarbonate, insulin, epinephrine, albumin, linoleic acid, dexamethasone, and glucagon.

16. 16. The system of claim 15, wherein the infusion system includes an enclosure that supports the multiple infusion pumps and the nutritional supplement.

17. 17. The system of claim 16, wherein the injection system includes a cooling system configured to cool an environment of the injection system; the cooling system is in communication with a controller; and the controller is configured to operate the cooling system to maintain a desired temperature of the environment of the injection system.

18. a storage container connected to the outlet of the enclosure and connectable to the outlet of the vasculature of the organ, the storage container being located upstream of the secondary pump and the primary pump; The system of claim 1 , further comprising:

19. a filter positioned at least partially within the storage container and configured to filter perfusion fluid passing through the storage container; 20. The system of claim 18, further comprising:

20. a purge line connected to the gas transfer unit and connected to the storage container 20. The system of claim 18, further comprising:

21. A method for growing or supporting an organ using the system comprising the steps of: housing the organ in an enclosure including a blood inlet and a blood outlet connected to a secondary loop of the system; connecting a primary loop of the system to a patient, the primary loop being connected to the secondary loop; pumping blood through the primary loop using a primary pump to deliver the blood through a patient; pumping blood through the secondary loop using a secondary pump, the secondary pump connected to the blood inlet and the blood outlet for pumping blood through the organ and the secondary loop; transferring gas to or from the blood using a gas transfer unit connected to a blood circuit including the primary loop and the secondary loop; receiving a sensor signal indicative of a condition of the blood; and Activating the pump system based on the sensor signal.

22. injecting nutrients into the system using an injection system connected to the secondary circuit.

22. The method of claim 21, further comprising:

23. 23. The method of claim 22, wherein nutrients are injected based on the sensor signal.

Citation Information

Patent Citations

  • Artificial organ system using new perfusion method

    JP2003250882A

  • Modified organ support devices

    US20050182349A1

  • Cross-circulation platform for recovery, regeneration, and maintenance of extracorporeal organs

    WO2018013849A1